πŸ‡ΊπŸ‡Έ FDA
Patent

US 11608367

Peptides for angiogenic therapy

granted A61KA61K38/00A61K47/60

Quick answer

US patent 11608367 (Peptides for angiogenic therapy) held by The Regents of the University of California expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K47/60, A61K9/0019, A61K9/127